Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-22 2:11 pm Sale | 13D | Morphic Holding Inc. MORF | Novo Holdings A/S | 1,845,030 4.9% | -205,416 (-10.02%) | View |
| 2022-02-09 5:18 pm Purchase | 13G | Arcellx Inc. ACLX | Novo Holdings A/S | 4,016,878 11.4% | 4,016,878 (New Position) | View |
| 2022-02-02 5:00 pm Purchase | 13G | EXSCIENTIA PLC AMERICAN DEPOSI EXAI | Novo Holdings A/S | 13,086,600 11% | 13,086,600 (New Position) | View |
| 2022-02-02 4:57 pm Purchase | 13G | EVOTEC SE AMERICAN DEPOSITARY EVO | Novo Holdings A/S | 17,894,807 10.2% | 17,894,807 (New Position) | View |
| 2022-02-02 4:55 pm Sale | 13G | GALERA THERAPEUTICS INC GRTX | Novo Holdings A/S | 2,459,021 9.3% | -500,000 (-16.90%) | View |
| 2022-01-31 4:28 pm Sale | 13D | ALIGOS THERAPEUTICS INC NE ALGS | Novo Holdings A/S | 1,950,000 4.9% | -664,563 (-25.42%) | View |
| 2022-01-27 3:31 pm Unchanged | 13D | OnKure Therapeutics Inc. OKUR | Novo Holdings A/S | 3,430,377 14% | 0 (Unchanged) | View |
| 2021-12-20 1:00 pm Unchanged | 13D | Cyteir Therapeutics Inc. CYT | Novo Holdings A/S | 4,840,413 13.6% | 0 (Unchanged) | View |
| 2021-11-22 4:08 pm Unchanged | 13D | SPRUCE BIOSCIENCES INC SPRB | Novo Holdings A/S | 4,514,336 19.2% | 0 (Unchanged) | View |
| 2021-11-22 4:06 pm Unchanged | 13D | NKARTA INC NKTX | Novo Holdings A/S | 2,793,865 8.5% | 0 (Unchanged) | View |
| 2021-11-22 4:03 pm Unchanged | 13D | BOLT BIOTHERAPEUTICS, INC BOLT | Novo Holdings A/S | 4,503,991 12% | 0 (Unchanged) | View |
| 2021-11-10 4:43 pm Purchase | 13D | IO BIOTECH INC IOBT | Novo Holdings A/S | 3,277,932 11.8% | 3,277,932 (New Position) | View |
| 2021-11-02 4:32 pm Sale | 13G | Freeline Therapeutics Holdings plc FRLN | Novo Holdings A/S | 1,785,563 4.99% | -575,666 (-24.38%) | View |
| 2021-11-01 4:03 pm Unchanged | 13D | Checkmate Pharmaceuticals Inc. CMPI | Novo Holdings A/S | 2,170,100 10% | 0 (Unchanged) | View |
| 2021-11-01 4:00 pm Unchanged | 13D | Morphic Holding Inc. MORF | Novo Holdings A/S | 2,050,446 5.6% | 0 (Unchanged) | View |
| 2021-10-27 4:02 pm Purchase | 13G | MINERVA SURGICAL INC N UTRS | Novo Holdings A/S | 2,057,132 7.2% | 2,057,132 (New Position) | View |
| 2021-09-20 4:20 pm Sale | 13G | INOGEN INC INGN | Novo Holdings A/S | 1,079,320 4.7% | -2,470,000 (-69.59%) | View |
| 2021-08-24 4:32 pm Unchanged | 13D | MIRUM PHARMACEUTICALS INC MIRM | Novo Holdings A/S | 2,445,147 8% | 0 (Unchanged) | View |
| 2021-08-11 8:20 pm Sale | 13D | Morphic Holding Inc. MORF | Novo Holdings A/S | 2,050,446 5.6% | -595,000 (-22.49%) | View |
| 2021-07-30 4:31 pm Sale | 13D | INOZYME PHARMA INC INZY | Novo Holdings A/S | 1,167,706 4.97% | -801,673 (-40.71%) | View |